HER2 Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
2 – 3 business days after placing order
HER2 Testing Trends and Forecast
The future of the global HER2 testing market looks promising with opportunities in the hospitals and diagnostic laboratories markets. The global HER2 testing market is expected to grow with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing significance of personalized medical approaches and surge in the prevalence of breast and gastric cancers.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
HER2 Testing by Segment
The study includes a forecast for the global HER2 testing by technique, cancer type, end use, and region.
HER2 Testing Market by Technique [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HER2 testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HER2 testing companies profiled in this report include-
Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to their cost-effectiveness and faster turnaround times.
Within this market, hospitals will remain the largest segment due to availability of specialized medical equipment and infrastructure.
North America will remain the largest region over the forecast period due to high prevalence of breast cancer.
Features of the Global HER2 Testing Market
Market Size Estimates: HER2 testing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: HER2 testing market size by technique, cancer type, end use, and region in terms of value ($B).
Regional Analysis: HER2 testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different techniques, cancer types, end uses, and regions for the HER2 testing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HER2 testing market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for HER2 testing market?
Answer: The global HER2 testing market is expected to grow with a CAGR of 7.1% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the HER2 testing market?
Answer: The major drivers for this market are increasing significance of personalized medical approaches and surge in the prevalence of breast and gastric cancers.
Q3. What are the major segments for HER2 testing market?
Answer: The future of the HER2 testing market looks promising with opportunities in the hospitals and diagnostic laboratories markets.
Q4. Who are the key HER2 testing market companies?
Answer: Some of the key HER2 testing companies are as follows:
Answer: Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to their cost-effectiveness and faster turnaround times.
Q6. In HER2 testing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high prevalence of breast cancer.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the HER2 testing market by technique (fluorescence in situ hybridization, dual-probe, single-probe, chromogenic in situ hybridization, and silver-enhanced in situ hybridization), cancer type (breast cancer and gastric cancer), end use (hospitals, diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to HER2 Testing Market, HER2 Testing Market Size, HER2 Testing Market Growth, HER2 Testing Market Analysis, HER2 Testing Market Report, HER2 Testing Market Share, HER2 Testing Market Trends, HER2 Testing Market Forecast, HER2 Testing Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
HER2 Testing Trends and Forecast
The future of the global HER2 testing market looks promising with opportunities in the hospitals and diagnostic laboratories markets. The global HER2 testing market is expected to grow with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing significance of personalized medical approaches and surge in the prevalence of breast and gastric cancers.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
HER2 Testing by Segment
The study includes a forecast for the global HER2 testing by technique, cancer type, end use, and region.
HER2 Testing Market by Technique [Shipment Analysis by Value from 2018 to 2030]:
- Fluorescence In Situ Hybridization
- Dual-Probe
- Single-Probe
- Chromogenic In Situ Hybridization
- Silver-Enhanced In Situ Hybridization
- Breast Cancer
- Gastric Cancer
- Hospitals
- Diagnostic Laboratories
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HER2 testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HER2 testing companies profiled in this report include-
- Abbott
- Hoffmann-La Roche
- Agilent Technologies
- Thermo Fisher Scientific
- Leica Biosystems
- Empire Genomics
- Bio-Genex Laboratories
Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to their cost-effectiveness and faster turnaround times.
Within this market, hospitals will remain the largest segment due to availability of specialized medical equipment and infrastructure.
North America will remain the largest region over the forecast period due to high prevalence of breast cancer.
Features of the Global HER2 Testing Market
Market Size Estimates: HER2 testing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: HER2 testing market size by technique, cancer type, end use, and region in terms of value ($B).
Regional Analysis: HER2 testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different techniques, cancer types, end uses, and regions for the HER2 testing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HER2 testing market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for HER2 testing market?
Answer: The global HER2 testing market is expected to grow with a CAGR of 7.1% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the HER2 testing market?
Answer: The major drivers for this market are increasing significance of personalized medical approaches and surge in the prevalence of breast and gastric cancers.
Q3. What are the major segments for HER2 testing market?
Answer: The future of the HER2 testing market looks promising with opportunities in the hospitals and diagnostic laboratories markets.
Q4. Who are the key HER2 testing market companies?
Answer: Some of the key HER2 testing companies are as follows:
- Abbott
- Hoffmann-La Roche
- Agilent Technologies
- Thermo Fisher Scientific
- Leica Biosystems
- Empire Genomics
- Bio-Genex Laboratories
Answer: Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to their cost-effectiveness and faster turnaround times.
Q6. In HER2 testing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high prevalence of breast cancer.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the HER2 testing market by technique (fluorescence in situ hybridization, dual-probe, single-probe, chromogenic in situ hybridization, and silver-enhanced in situ hybridization), cancer type (breast cancer and gastric cancer), end use (hospitals, diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to HER2 Testing Market, HER2 Testing Market Size, HER2 Testing Market Growth, HER2 Testing Market Analysis, HER2 Testing Market Report, HER2 Testing Market Share, HER2 Testing Market Trends, HER2 Testing Market Forecast, HER2 Testing Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL HER2 TESTING MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global HER2 Testing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global HER2 Testing Market by Technique
3.3.1: Fluorescence in situ hybridization
3.3.2: Dual-probe
3.3.3: Single-probe
3.3.4: Chromogenic in situ hybridization
3.3.5: Silver-enhanced in situ hybridization
3.4: Global HER2 Testing Market by Cancer Type
3.4.1: Breast Cancer
3.4.2: Gastric Cancer
3.5: Global HER2 Testing Market by End Use
3.5.1: Hospitals
3.5.2: Diagnostic Laboratories
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global HER2 Testing Market by Region
4.2: North American HER2 Testing Market
4.2.1: North American HER2 Testing Market by Technique: Fluorescence in situ hybridization, Dual-probe, Single-probe, Chromogenic in situ hybridization, and Silver-enhanced in situ hybridization
4.2.2: North American HER2 Testing Market by End Use: Hospitals, Diagnostic Laboratories, and Others
4.3: European HER2 Testing Market
4.3.1: European HER2 Testing Market by Technique: Fluorescence in situ hybridization, Dual-probe, Single-probe, Chromogenic in situ hybridization, and Silver-enhanced in situ hybridization
4.3.2: European HER2 Testing Market by End Use: Hospitals, Diagnostic Laboratories, and Others
4.4: APAC HER2 Testing Market
4.4.1: APAC HER2 Testing Market by Technique: Fluorescence in situ hybridization, Dual-probe, Single-probe, Chromogenic in situ hybridization, and Silver-enhanced in situ hybridization
4.4.2: APAC HER2 Testing Market by End Use: Hospitals, Diagnostic Laboratories, and Others
4.5: ROW HER2 Testing Market
4.5.1: ROW HER2 Testing Market by Technique: Fluorescence in situ hybridization, Dual-probe, Single-probe, Chromogenic in situ hybridization, and Silver-enhanced in situ hybridization
4.5.2: ROW HER2 Testing Market by End Use: Hospitals, Diagnostic Laboratories, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global HER2 Testing Market by Technique
6.1.2: Growth Opportunities for the Global HER2 Testing Market by Cancer Type
6.1.3: Growth Opportunities for the Global HER2 Testing Market by End Use
6.1.4: Growth Opportunities for the Global HER2 Testing Market by Region
6.2: Emerging Trends in the Global HER2 Testing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global HER2 Testing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HER2 Testing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Abbott
7.2: Hoffmann-La Roche
7.3: Agilent Technologies
7.4: Thermo Fisher Scientific
7.5: Leica Biosystems
7.6: Empire Genomics
7.7: Bio-Genex Laboratories
2. GLOBAL HER2 TESTING MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global HER2 Testing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global HER2 Testing Market by Technique
3.3.1: Fluorescence in situ hybridization
3.3.2: Dual-probe
3.3.3: Single-probe
3.3.4: Chromogenic in situ hybridization
3.3.5: Silver-enhanced in situ hybridization
3.4: Global HER2 Testing Market by Cancer Type
3.4.1: Breast Cancer
3.4.2: Gastric Cancer
3.5: Global HER2 Testing Market by End Use
3.5.1: Hospitals
3.5.2: Diagnostic Laboratories
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global HER2 Testing Market by Region
4.2: North American HER2 Testing Market
4.2.1: North American HER2 Testing Market by Technique: Fluorescence in situ hybridization, Dual-probe, Single-probe, Chromogenic in situ hybridization, and Silver-enhanced in situ hybridization
4.2.2: North American HER2 Testing Market by End Use: Hospitals, Diagnostic Laboratories, and Others
4.3: European HER2 Testing Market
4.3.1: European HER2 Testing Market by Technique: Fluorescence in situ hybridization, Dual-probe, Single-probe, Chromogenic in situ hybridization, and Silver-enhanced in situ hybridization
4.3.2: European HER2 Testing Market by End Use: Hospitals, Diagnostic Laboratories, and Others
4.4: APAC HER2 Testing Market
4.4.1: APAC HER2 Testing Market by Technique: Fluorescence in situ hybridization, Dual-probe, Single-probe, Chromogenic in situ hybridization, and Silver-enhanced in situ hybridization
4.4.2: APAC HER2 Testing Market by End Use: Hospitals, Diagnostic Laboratories, and Others
4.5: ROW HER2 Testing Market
4.5.1: ROW HER2 Testing Market by Technique: Fluorescence in situ hybridization, Dual-probe, Single-probe, Chromogenic in situ hybridization, and Silver-enhanced in situ hybridization
4.5.2: ROW HER2 Testing Market by End Use: Hospitals, Diagnostic Laboratories, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global HER2 Testing Market by Technique
6.1.2: Growth Opportunities for the Global HER2 Testing Market by Cancer Type
6.1.3: Growth Opportunities for the Global HER2 Testing Market by End Use
6.1.4: Growth Opportunities for the Global HER2 Testing Market by Region
6.2: Emerging Trends in the Global HER2 Testing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global HER2 Testing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HER2 Testing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Abbott
7.2: Hoffmann-La Roche
7.3: Agilent Technologies
7.4: Thermo Fisher Scientific
7.5: Leica Biosystems
7.6: Empire Genomics
7.7: Bio-Genex Laboratories
